Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1114

1.

Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.

Khanna AK, Xu J, Uber PA, Burke AP, Baquet C, Mehra MR.

Circulation. 2009 Nov 3;120(18):1814-21. doi: 10.1161/CIRCULATIONAHA.108.840223. Epub 2009 Oct 19.

2.

Cytomegalovirus infection and cardiac allograft vasculopathy.

Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Häyry PJ, Lemström KB.

Transpl Infect Dis. 1999 Jun;1(2):115-26. Review.

PMID:
11428979
3.

Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.

Xia D, Sanders A, Shah M, Bickerstaff A, Orosz C.

Transplantation. 2001 Sep 15;72(5):907-14.

PMID:
11571458
4.

Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.

Ritter T, Yang J, Dannowski H, Vogt K, Volk HD, Pleyer U.

Transpl Immunol. 2007 Nov;18(2):101-7. Epub 2007 Jun 13.

PMID:
18005852
5.

Influence of gender on allograft rejection in a rat heart transplant model.

Takami H, Backer CL, Crawford SE, Zales VR, Mavroudis C.

J Heart Lung Transplant. 1995 May-Jun;14(3):529-36.

PMID:
7654736
6.

Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation.

Palombo JD, Burke PA, Moldawer LL, Forse RA, Lewis WD, Jenkins RL.

J Am Coll Surg. 1994 Aug;179(2):209-19.

PMID:
7519108
7.

Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: insights from double knockout mice.

Räisänen-Sokolowski A, Glysing-Jensen T, Russell ME.

J Heart Lung Transplant. 1999 Aug;18(8):735-43.

PMID:
10512519
8.

Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.

Mehra MR, Stapleton DD, Ventura HO, Escobar A, Cassidy CA, Smart FW, Collins TJ, Ramee SR, White CJ.

Circulation. 1994 Nov;90(5 Pt 2):II78-82.

PMID:
7955289
9.

Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation.

Methe H, Zimmer E, Grimm C, Nabauer M, Koglin J.

Transplantation. 2004 Nov 15;78(9):1324-31.

PMID:
15548971
10.

Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.

Krasinskas AM, Eiref SD, McLean AD, Kreisel D, Gelman AE, Popma SH, Moore JS, Rosengard BR.

Transplantation. 2000 Aug 15;70(3):514-21.

PMID:
10949196
11.

Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA.

Zhang QW, Tomita Y, Matsuzaki G, Uchida T, Yoshikawa M, Nakashima Y, Sueishi K, Nomoto K, Yasui H.

Transpl Int. 2001 Jun;14(3):143-52.

12.

Mast cells in acute and chronic rejection of rat cardiac allografts--a major source of basic fibroblast growth factor.

Koskinen PK, Kovanen PT, Lindstedt KA, Lemström KB.

Transplantation. 2001 Jun 27;71(12):1741-7.

PMID:
11455252
13.

Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.

Yang J, Popoola J, Khandwala S, Vadivel N, Vanguri V, Yuan X, Dada S, Guleria I, Tian C, Ansari MJ, Shin T, Yagita H, Azuma M, Sayegh MH, Chandraker A.

Circulation. 2008 Feb 5;117(5):660-9. doi: 10.1161/CIRCULATIONAHA.107.741025. Epub 2008 Jan 22.

14.

Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts.

Pratschke J, Paz D, Wilhelm MJ, Laskowski I, Kofla G, Vergopoulos A, MacKenzie HJ, Tullius SG, Neuhaus P, Hancock WW, Volk HD, Tilney NL.

Transplantation. 2004 Jan 15;77(1):43-8.

PMID:
14724433
15.

Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation.

Densem CG, Hutchinson IV, Yonan N, Brooks NH.

J Heart Lung Transplant. 2001 Dec;20(12):1265-73.

PMID:
11744409
16.

Donor DNA can be detected in recipient tissues during rejection of allograft.

Olszewski WL, Durlik M, Lukomska B, Religa P, Ziolkowska H, Janczewska S, Cybulska E, Soin J, Gaciong Z, Interewicz B.

Transpl Int. 2000;13 Suppl 1:S461-4.

17.

Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient.

Yamani MH, Cook DJ, Tuzcu EM, Paul P, Ratliff NB, Yu Y, Hobbs R, Rincon G, Bott-Silverman C, Smedira N, Young JB, Starling RC.

J Heart Lung Transplant. 2005 Aug;24(8):1014-8.

PMID:
16102435
18.

Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.

den Dulk M, Wang C, Li J, Clark DA, Hibberd AD, Terpstra OT, McCaughan GW, Bishop GA.

Transpl Immunol. 2004 Nov;13(3):177-84.

PMID:
15381200
19.
20.

Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection.

Singh NP, Guo L, Mhoyan A, Shirwan H.

Transplantation. 2003 Mar 15;75(5):586-90.

PMID:
12640294
Items per page

Supplemental Content

Write to the Help Desk